731 related articles for article (PubMed ID: 23010360)
21. [Effects of BmKIM on sodium current of isolated cardiomyocytes, transmembrane action potential and aconitine induced arrhythmia in vivo in rabbits].
Wang T; Huang CX; Jiang H; Tang QZ; Yang B; Li GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):102-7. PubMed ID: 19719982
[TBL] [Abstract][Full Text] [Related]
22. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
[TBL] [Abstract][Full Text] [Related]
23. The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers.
Fedida D; Orth PM; Hesketh JC; Ezrin AM
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S71-S78. PubMed ID: 16686685
[TBL] [Abstract][Full Text] [Related]
24. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity.
Bonatti R; Silva AF; Batatinha JA; Sobrado LF; Machado AD; Varone BB; Nearing BD; Belardinelli L; Verrier RL
Heart Rhythm; 2014 Oct; 11(10):1827-35. PubMed ID: 24953379
[TBL] [Abstract][Full Text] [Related]
25. Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes.
Luo A; Ma J; Song Y; Qian C; Wu Y; Zhang P; Wang L; Fu C; Cao Z; Shryock JC
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(3):H455-61. PubMed ID: 24322614
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
Antzelevitch C; Belardinelli L; Zygmunt AC; Burashnikov A; Di Diego JM; Fish JM; Cordeiro JM; Thomas G
Circulation; 2004 Aug; 110(8):904-10. PubMed ID: 15302796
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
Larsen AP; Olesen SP; Grunnet M; Poelzing S
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
[TBL] [Abstract][Full Text] [Related]
28. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
29. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain.
Hoyer K; Song Y; Wang D; Phan D; Balschi J; Ingwall JS; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2011 May; 337(2):513-23. PubMed ID: 21325441
[TBL] [Abstract][Full Text] [Related]
30. Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015.
Macianskiene R; Bito V; Raeymaekers L; Brandts B; Sipido KR; Mubagwa K
Br J Pharmacol; 2003 Aug; 139(8):1469-79. PubMed ID: 12922934
[TBL] [Abstract][Full Text] [Related]
31. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
Wang WQ; Robertson C; Dhalla AK; Belardinelli L
J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
[TBL] [Abstract][Full Text] [Related]
32. ATX-II effects on the apparent location of M cells in a computational model of a human left ventricular wedge.
Dos Santos RW; Otaviano Campos F; Neumann Ciuffo L; Nygren A; Giles W; Koch H
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S86-S95. PubMed ID: 16686688
[TBL] [Abstract][Full Text] [Related]
33. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
34. Eleutheroside B, a selective late sodium current inhibitor, suppresses atrial fibrillation induced by sea anemone toxin II in rabbit hearts.
Zhang PP; Guo ZF; Zhang PH; Liu ZP; Song L; Zhang ZF; Jia YZ; Cao ZZ; Ma JH
Acta Pharmacol Sin; 2021 Feb; 42(2):209-217. PubMed ID: 32612277
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
Chi L; Belardinelli L; Zeng A; Hirakawa R; Rajamani S; Ling H; Dhalla AK
Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1313-20. PubMed ID: 26993228
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
37. Use-Dependent Block of Human Cardiac Sodium Channels by GS967.
Potet F; Vanoye CG; George AL
Mol Pharmacol; 2016 Jul; 90(1):52-60. PubMed ID: 27136942
[TBL] [Abstract][Full Text] [Related]
38. The novel late Na
Rajamani S; Liu G; El-Bizri N; Guo D; Li C; Chen XL; Kahlig KM; Mollova N; Elzein E; Zablocki J; Belardinelli L
Br J Pharmacol; 2016 Nov; 173(21):3088-3098. PubMed ID: 27449698
[TBL] [Abstract][Full Text] [Related]
39. I
Hou JW; Li W; Fei YD; Chen YH; Wang Q; Wang YP; Li YG
J Physiol Biochem; 2018 Feb; 74(1):57-67. PubMed ID: 29243206
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of the late sodium current has no adverse effect on electrophysiological or contractile function of the normal heart.
Fernandes S; Hoyer K; Liu G; Wang WQ; Dhalla AK; Belardinelli L; Rajamani S
J Cardiovasc Pharmacol; 2014 Jun; 63(6):512-9. PubMed ID: 24406487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
